Katleen Vereecken

Research output

Research output per year 1995 1997 1998 1999 2000 2006 2008 2011 2012 2013 2022 2023

• 31 A1: Web of Science-article
• 2 Letter

Research output per year

Research output per year

Search results

• 2023

  Genome Mining Uncovers NRPS and PKS Clusters in Rothia dentocariosa with Inhibitory Activity against Neisseria Species

  Akomoneh, E. A., Gestels, Z., Abdellati, S., Vereecken, K., Bartholomeeusen, K., Van den Bossche, D., Kenyon, C. & Manoharan-Basil, S. S., 2023, In: Antibiotics-Basel. 12, 11, 12 p., 1592.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • non-ribosomal peptide synthase 100%
  • Polyketide Synthases 95%
  • Polyketide 74%
  • Mining 71%
  • Complex Mixtures 69%
  8 Downloads (Pure)
• 2022

  Chikungunya virus' high genomic plasticity enables rapid adaptation to restrictive A549 cells

  De Caluwé, L., Heyndrickx, L., Coppens, S., Vereecken, K., Quiñones-Mateu, M. E., Merits, A., Ariën, K. K. & Bartholomeeusen, K., 2022, In: Viruses. 14, 2, 15 p., 282.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Chikungunya virus 100%
  • A549 Cells 79%
  • Aedes 19%
  • Viruses 10%
  • Vero Cells 9%
  142 Downloads (Pure)

• Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant

  Ariën, K. K., Heyndrickx, L., Michiels, J., Vereecken, K., Van Lent, K., Coppens, S., Willems, B., Pannus, P., Martens, G. A., Van Esbroeck, M., Goossens, M. E., Marchant, A., Bartholomeeusen, K. & Desombere, I., 2022, In: Vaccines. 7, 1, 3 p., 35.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • SARS Virus 100%
  • Dose 51%
  • Infections 32%
  51 Downloads (Pure)
• 2021

  The CD147 protein complex is involved in entry of chikungunya virus and related alphaviruses in human cells

  De Caluwé, L., Coppens, S., Vereecken, K., Daled, S., Dhaenens, M., Van Ostade, X., Deforce, D., Ariën, K. K. & Bartholomeeusen, K., 2021, In: Frontiers in Microbiology. 12, 615165.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Chikungunya virus 100%
  • Clustered Regularly Interspaced Short Palindromic Repeats 16%
  40 Downloads (Pure)
• 2018

  A Chikungunya virus trans-replicase system reveals the importance of delayed nonstructural polyprotein processing for efficient replication complex formation in mosquito cells

  Bartholomeeusen, K., Utt, A., Coppens, S., Rausalu, K., Vereecken, K., Arien, K. K. & Merits, A., 2018, In: Journal of Virology. 92, 14, 20 p., ARTN e00152-18.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  File

  • Chikungunya virus 100%
  • Aedes 12%
  • RNA Interference 9%
  • Viral Structures 6%
  • enhanced green fluorescent protein 6%
  43 Downloads (Pure)
• 2016

  Resistance and cross-resistance profile of the diaryltriazine NNRTI and candidate microbicide UAMC01398

  Ariën, K. K., Venkatraj, M., Michiels, J., Joossens, J., Vereecken, K., Van der Veken, P., Heeres, J., De Winter, H., Heyndrickx, L., Augustyns, K. & Vanham, G., 2016, In: Journal of Antimicrobial Chemotherapy. 71, 5, p. 1159-1168

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  • Dapivirine 100%
  • Reverse Transcriptase Inhibitors 65%
  • Viruses 36%
• 2013

  Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission

  Ariën, K. K., Venkatraj, M., Michiels, J., Joossens, J., Vereecken, K., Van der Veken, P., Abdellati, S., Cuylaerts, V., Crucitti, T., Heyndrickx, L., Heeres, J., Augustyns, K., Lewi, P. J. & Vanham, G., 2013, In: Journal of Antimicrobial Chemotherapy. 68, 9, p. 2038-2047 10 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  • Dapivirine 100%
  • Reverse Transcriptase Inhibitors 65%
  • Libraries 32%
  • Viruses 24%
  • Proof of Concept Study 22%

• Selected HIV-1 env trimeric formulations act as potent immunogens in a rabbit vaccination model

  Heyndrickx, L., Stewart-Jones, G., Jansson, M., Schuitemaker, H., Bowles, E., Buonaguro, L., Grevstad, B., Vinner, L., Vereecken, K., Parker, J., Ramaswamy, M., Biswas, P., Vanham, G., Scarlatti, G. & Fomsgaard, A., 2013, In: PLoS ONE. 8, 9, p. e74552

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • GP 140 100%
  • HIV-1 66%
  • AIDS Vaccines 19%
  • Ammonium Compounds 19%
  • Allergy and Immunology 16%
  49 Downloads (Pure)

• The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody

  Balla-Jhagjhoorsingh, S., Corti, D., Heyndrickx, L., Willems, E., Vereecken, K., Davis, D. & Vanham, G., 2013, In: PLoS ONE. 8, 7, p. e68863

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • Glycosylation 100%
  • HIV-1 84%
  • AIDS Vaccines 25%
  • Site-Directed Mutagenesis 20%
  • Viruses 12%
  37 Downloads (Pure)
• 2012

  Interleukin-12p70 expression by dendritic cells of HIV-1-infected patients fails to stimulate gag-specific immune responses

  Van Gulck, E., Cools, N., Atkinson, D., Bracke, L., Vereecken, K., Vekemans, M., Van Tendeloo, V. F. I., Berneman, Z. N. & Vanham, G., 2012, In: Clinical and Developmental Immunology. 184979, p. 1-11 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • HIV-1 100%
  45 Downloads (Pure)

• MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency

  Grupping, K., Selhorst, P., Michiels, J., Vereecken, K., Heyndrickx, L., Kessler, P., Vanham, G., Martin, L. & Ariën, K. K., 2012, In: Retrovirology. 9, 36, p. 1-16 16 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  Open Access

  File

  • HIV-1 100%
  • Viruses 28%
  • CD4 Antigens 18%
  • Clone Cells 11%
  58 Downloads (Pure)
• 2011

  Characterization of neutralizing profiles in HIV-1 infected patients from whom the HJ16, HGN194 and HK20 mAbs were obtained

  Balla-Jhagjhoorsingh, SS., Willems, B., Heyndrickx, L., Heyndrickx, L., Vereecken, K., Janssens, W., Seaman, MS., Corti, D., Lanzavecchia, A., Davis, D. & Vanham, G., 2011, In: PLoS ONE. 6, 10, p. e25488 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  File
  28 Downloads (Pure)

• Human Immunodeficiency Virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides

  Selhorst, P., Vazquez, AC., Terrazas-Aranda, K., Michiels, J., Vereecken, K., Heyndrickx, L., Weber, J., Quiñones-Mateu, ME., Ariën, KK. & Vanham, G., 2011, In: Antimicrobial Agents and Chemotherapy. 55, 4, p. 1403-1413 11 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

  File

  • Reverse Transcriptase Inhibitors 100%
  • HIV-1 72%
  • UC 781 53%
  • Nevirapine 24%
  • Viruses 24%
  42 Downloads (Pure)
• 2009

  HIV type 1 subtype A envelope genetic evolution in a slow progressing individual with consistent broadly neutralizing antibodies

  Dieltjens, T., Loots, N., Vereecken, K., Grupping, K., Heyndrickx, L., Bottieau, E., Vanham, G., Davis, D. & Janssens, W., 2009, In: AIDS Research and Human Retroviruses. 25, 11, p. 1165-1169 5 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2008

  Antiviral compounds show enhanced activity in HIV-1 single cycle pseudovirus assays as compared to classical PBMC assays

  Heyndrickx, L., Vermoesen, T., Vereecken, K., Kurth, J., Coppens, S., Aerts, L., Ohagen, A., Van Herrewege, Y., Lewi, P. & Vanham, G., 2008, In: Journal of Virological Methods. 148, 1-2, p. 166-173 8 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific t-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals

  Van Gulck, E. R., Vanham, G., Heyndrickx, L., Coppens, S., Vereecken, K., Atkinson, D., Florence, E., Kint, I., Berneman, ZN. & Van Tendeloo, V., 2008, In: Journal of Virology. 82, 7, p. 3561-3573 13 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes

  Beels, D., Heyndrickx, L., Vereecken, K., Vermoesen, T., Michiels, L., Vanham, G. & Kestens, L., 2008, In: Journal of Virological Methods. 147, 1, p. 99-107 9 p.

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2006

  Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins

  Van Gulck, E., Ponsaerts, P., Heyndrickx, L., Vereecken, K., Moerman, F., De Roo, A., Colebunders, R., Van den Bosch, G., Van Bockstaele, DR., Van Tendeloo, VFI., Allard, S., Verrier, B., Maranon, C., Hoeffel, G., Hosmalin, A., Berneman, ZW. & Vanham, G., 2006, In: Blood. 107, 5, p. 1818-1827

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Mother-to-child transmission of different HIV-1 subtypes among ARV naive infected pregnant women in Nigeria

  Odaibo, GN., Olaleye, DO., Heyndrickx, L., Vereecken, K., De Houwer, K. & Janssens, W., 2006, In: Revista do Instituto de Medicina Tropical de Sao Paulo. 48, 2, p. 77-80

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 2002

  Predominance of infection with HIV-1 circulating recombinant form CRF02_AG in major Cameroonian cities and towns [letter]

  Nyambi, P., Heyndrickx, L., Vereecken, K., Burda, S., De Houwer, K., Coppens, S., Urbanski, M., Williams, C., Ndumbe, P. & Janssens, W., 2002, In: AIDS. 16, p. 295-296

  Research output: Contribution to journal › Letter › peer-review
• 2000

  Development of a one-tube multiplex reverse transcriptase-polymerase chain reaction assay for the simultaneous amplification of HIV type 1 group M gag and env heteroduplex mobility assay fragments

  Cham, F., Heyndrickx, L., Janssens, W., Vereecken, K., De Houwer, K., Coppens, S., Van der Auwera, G., Whittle, H. & van der Groen, G., 2000, In: AIDS Research and Human Retroviruses. 16, 15, p. 1503-1505

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• HIV-1 genetic variability in Cameroon [letter]

  Heyndrickx, L., Janssens, W., Ndumbe, PM., Vereecken, K., Coppens, S., De Houwer, K., Fransen, K., Van der Auwera, G. & van der Groen, G., 2000, In: AIDS. 14, p. 1862-1864

  Research output: Contribution to journal › Letter › peer-review

• Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay

  Heyndrickx, L., Janssens, W., Zekeng, L., Musonda, R., Anagonou, S., Van der Auwera, G., Coppens, S., Vereecken, K., De Witte, K., Van Rampelbergh, R., Kahindo, M., Morison, L., McCutchan, FE., Carr, JK., Albert, J., Essex, M., Goudsmit, J., Asjö, B., Salminen, M., Buvé, A., & 1 othersStudy Group on Heterogeneity of HIV Epidemics in African, C., 2000, In: Journal of Virology. 74, p. 363-370

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Study of HIV type 1 gag/env variability in The Gambia, using a multiplex DNA polymerase chain reaction

  Cham, F., Heyndrickx, L., Janssens, W., Van der Auwera, G., Vereecken, K., De Houwer, K., Coppens, S., Whittle, H. & van der Groen, G., 2000, In: AIDS Research and Human Retroviruses. 17, 17, p. 1915-1919

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 1999

  Interpatient genetic variability of HIV-1 group O

  Janssens, W., Heyndrickx, L., Van der Auwera, G., Nkengasong, J., Beirnaert, E., Vereecken, K., Coppens, S., Willems, B., Fransen, K., Peeters, M., Ndumbe, P., Delaporte, E. & van der Groen, G., 1999, In: AIDS. 13, p. 41-48

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up

  Janssens, W., Nkengasong, J., Heyndrickx, L., Van der Auwera, G., Vereecken, K., Coppens, S., Willems, B., Beirnaert, E., Fransen, K., Peeters, M. & van der Groen, G., 1999, In: AIDS Research and Human Retroviruses. 15, p. 1325-1332

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 1998

  Design and evaluation of an in-house HIV-1 (group M and O) SIVmnd and SIVcpz antigen capture assay

  Beirnaert, E., Willems, B., Peeters, M., Bouckaert, A., Heyndrickx, L., Zhong, P., Vereecken, K., Coppens, S., Davis, D., Ndumbe, P., Janssens, W. & van der Groen, G., 1998, In: Journal of Virological Methods. 73, p. 65-70

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• Differential diagnosis of HIV type 1 group O and M infection by polymerase chain reaction and PstI restriction analysis of the pol gene fragments

  Heyndrickx, L., Janssens, W., Gürtler, L., Zekeng, L., Loussert-Ajaka, I., Vereecken, K., Willems, B., Coppens, S., Ndumbe, P., Fransen, K., Saman, E., Alary, M. & van der Groen, G., 1998, In: AIDS Research and Human Retroviruses. 14, p. 973-977

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• HIV type 1 C2V3 env diversity among Belgian individuals

  Heyndrickx, L., Janssens, W., Coppens, S., Vereecken, K., Willems, B., Fransen, K., Colebunders, R., Vandenbruaene, M. & van der Groen, G., 1998, In: AIDS Research and Human Retroviruses. 14, p. 1291-1296

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 1997

  Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes

  Gobbers, E., Fransen, K., Oosterlaken, T., Janssens, W., Heyndrickx, L., Ivens, T., Vereecken, K., Schoones, R., van de Wiel, P. & van der Groen, G., 1997, In: Journal of Virological Methods. 66, p. 293-301

  Research output: Contribution to journal › A1: Web of Science-article › peer-review

• The neutralization relationship of HIV type 1, HIV type 2, and SIVcpz is reflected in the genetic diversity that distinguishes them

  Nyambi, PN., Willems, B., Janssens, W., Fransen, K., Nkengasong, J., Peeters, M., Vereecken, K., Heyndrickx, L., Piot, P. & van der Groen, G., 1997, In: AIDS Research and Human Retroviruses. 13, p. 7-17

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 1996

  Genetic variability of HIV type 1 in Bénin

  Heyndrickx, L., Janssens, W., Alary, M., Fransen, K., Vereecken, K., Coppens, S., Willems, B., Davo, N., Guèdèmè, A., Baganizi, E., Joly, J. & van der Groen, G., 1996, In: AIDS Research and Human Retroviruses. 12, p. 1495-1497

  Research output: Contribution to journal › A1: Web of Science-article › peer-review
• 1995

  Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses

  Nyambi, PN., Nkengasong, J., Peeters, M., Simon, F., Eberle, J., Janssens, W., Fransen, K., Willems, B., Vereecken, K., Heyndrickx, L., Piot, P. & van der Groen, G., 1995, In: Journal of Infectious Diseases. 172, p. 1228-1237

  Research output: Contribution to journal › A1: Web of Science-article › peer-review